CompletedEUCTR 2006-002553-80
ADHD hos intagna inom Kriminalvården - förekomst/diagnos/behandling/uppföljning
This historical record does not confirm current site availability.
Historical research recordSweden
Understand this study
What did researchers investigate?
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.
- Listed locations
- Sweden
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateNot clearly listed
- Recruitment status
- Completed
- Enrollment listed in the registry
- Not clearly listed
- Sponsor
- Karolinska Universitetssjukhuset
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- Sweden
- Age range
- Not clearly listed
- Official registry ID
- EUCTR 2006-002553-80
- Official title
Show the full official title
ADHD hos intagna inom Kriminalvården - förekomst/diagnos/behandling/uppföljning
Get this study by email
Recruitment & locations
CompletedSweden
Registry details
Historical country statuses
- Sweden — Completed
Questions about this study
Who is behind this study?
The study sponsor is Karolinska Universitetssjukhuset.
Want to explore more studies?
Explore studiesRelated studies
A 40-week, randomized, double-blind, placebo-controlled, multicenter efficacy and safety study of Ritalin® LA in the treatment of adult patients with childhood-onset ADHD
A 6-month, open-label extension to a 40-week, randomized, double-blind, placebo-controlled, multicenter efficacy and safety study of Ritalin® LA in the treatment of adult patients with childhood-on...